BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25103687)

  • 1. Biased estimates of clonal evolution and subclonal heterogeneity can arise from PCR duplicates in deep sequencing experiments.
    Smith EN; Jepsen K; Khosroheidari M; Rassenti LZ; D'Antonio M; Ghia EM; Carson DA; Jamieson CH; Kipps TJ; Frazer KA
    Genome Biol; 2014 Aug; 15(8):420. PubMed ID: 25103687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of unique molecular identifiers in TruSeq adapters improves the accuracy of quantitative sequencing.
    Hong J; Gresham D
    Biotechniques; 2017 Nov; 63(5):221-226. PubMed ID: 29185922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale.
    Barber LJ; Davies MN; Gerlinger M
    Curr Opin Genet Dev; 2015 Feb; 30():1-6. PubMed ID: 25555261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bias from removing read duplication in ultra-deep sequencing experiments.
    Zhou W; Chen T; Zhao H; Eterovic AK; Meric-Bernstam F; Mills GB; Chen K
    Bioinformatics; 2014 Apr; 30(8):1073-1080. PubMed ID: 24389657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the necessity of PCR duplicate removal from next-generation sequencing data and a comparison of approaches.
    Ebbert MT; Wadsworth ME; Staley LA; Hoyt KL; Pickett B; Miller J; Duce J; ; Kauwe JS; Ridge PG
    BMC Bioinformatics; 2016 Jul; 17 Suppl 7(Suppl 7):239. PubMed ID: 27454357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia.
    Nadeu F; Delgado J; Royo C; Baumann T; Stankovic T; Pinyol M; Jares P; Navarro A; Martín-García D; Beà S; Salaverria I; Oldreive C; Aymerich M; Suárez-Cisneros H; Rozman M; Villamor N; Colomer D; López-Guillermo A; González M; Alcoceba M; Terol MJ; Colado E; Puente XS; López-Otín C; Enjuanes A; Campo E
    Blood; 2016 Apr; 127(17):2122-30. PubMed ID: 26837699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A computational method for estimating the PCR duplication rate in DNA and RNA-seq experiments.
    Bansal V
    BMC Bioinformatics; 2017 Mar; 18(Suppl 3):43. PubMed ID: 28361665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.
    Sutton LA; Rosenquist R
    Expert Rev Hematol; 2015 Feb; 8(1):71-8. PubMed ID: 25345442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.
    Donmez N; Malikic S; Wyatt AW; Gleave ME; Collins CC; Sahinalp SC
    J Comput Biol; 2017 Jun; 24(6):515-523. PubMed ID: 28056180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the causes, consequences, and avoidance of PCR duplicates: Towards a theory of library complexity.
    Rochette NC; Rivera-Colón AG; Walsh J; Sanger TJ; Campbell-Staton SC; Catchen JM
    Mol Ecol Resour; 2023 Aug; 23(6):1299-1318. PubMed ID: 37062860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tarSVM: Improving the accuracy of variant calls derived from microfluidic PCR-based targeted next generation sequencing using a support vector machine.
    Gillies CE; Otto EA; Vega-Warner V; Robertson CC; Sanna-Cherchi S; Gharavi A; Crawford B; Bhimma R; Winkler C; ; ; Kang HM; Sampson MG
    BMC Bioinformatics; 2016 Jun; 17(1):233. PubMed ID: 27287006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TargetClone: A multi-sample approach for reconstructing subclonal evolution of tumors.
    Nieboer MM; Dorssers LCJ; Straver R; Looijenga LHJ; de Ridder J
    PLoS One; 2018; 13(11):e0208002. PubMed ID: 30496231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance evaluation of commercial library construction kits for PCR-based targeted sequencing using a unique molecular identifier.
    Chung J; Lee KW; Lee C; Shin SH; Kyung S; Jeon HJ; Kim SY; Cho E; Yoo CE; Son DS; Park WY; Park D
    BMC Genomics; 2019 Mar; 20(1):216. PubMed ID: 30871467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia.
    Mosquera Orgueira A; Antelo Rodríguez B; Díaz Arias JÁ; Bello López JL
    Blood Cancer J; 2019 Sep; 9(10):78. PubMed ID: 31570692
    [No Abstract]   [Full Text] [Related]  

  • 15. Reconstruction of clonal trees and tumor composition from multi-sample sequencing data.
    El-Kebir M; Oesper L; Acheson-Field H; Raphael BJ
    Bioinformatics; 2015 Jun; 31(12):i62-70. PubMed ID: 26072510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new workflow for whole-genome sequencing of single human cells.
    Binder V; Bartenhagen C; Okpanyi V; Gombert M; Moehlendick B; Behrens B; Klein HU; Rieder H; Ida Krell PF; Dugas M; Stoecklein NH; Borkhardt A
    Hum Mutat; 2014 Oct; 35(10):1260-70. PubMed ID: 25066732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ultra high-throughput 16S rRNA gene amplicon sequencing library preparation method for the Illumina HiSeq platform.
    de Muinck EJ; Trosvik P; Gilfillan GD; Hov JR; Sundaram AYM
    Microbiome; 2017 Jul; 5(1):68. PubMed ID: 28683838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing data.
    Oesper L; Mahmoody A; Raphael BJ
    Genome Biol; 2013 Jul; 14(7):R80. PubMed ID: 23895164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Sequencing and Analysis Methods in Chronic Lymphocytic Leukemia.
    Quesada V; Araujo-Voces M; Pérez-Silva JG; Velasco G; López-Otín C
    Methods Mol Biol; 2019; 1881():319-325. PubMed ID: 30350214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib.
    Gángó A; Alpár D; Galik B; Marosvári D; Kiss R; Fésüs V; Aczél D; Eyüpoglu E; Nagy N; Nagy Á; Krizsán S; Reiniger L; Farkas P; Kozma A; Ádám E; Tasnády S; Réti M; Matolcsy A; Gyenesei A; Mátrai Z; Bödör C
    Int J Cancer; 2020 Jan; 146(1):85-93. PubMed ID: 31180577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.